Early-stage clinical data from our company and others point to the Wnt/β-catenin pathway as a new avenue for targeting ...

Ryan Haumschild, PharmD, MS, MBA, drives an expert discussion focused on challenges associated with clinical pathway utilization in treating patients with HCC. The panel discussion focused on the ...

Expanding the Multidisciplinary Team in Prediagnostic Care of Lung Cancer: How Else Can We Improve Time to Targeted Treatment in Metastatic Non–Small-Cell Lung Cancer? In the article that accompanies ...

In one patient with recurrent IDH1 wild-type, MGMT-methylated glioblastoma (GBM), NEO212 treatment resulted in a partial response, including an approximately 60% reduction in tumor size, followed by ...

Findings from the American Society for Radiation Oncology (ASTRO) highlight the growing financial strain at freestanding clinics, including those that say they will lose half their annual revenue.

Cardiovascular–kidney–metabolic (CKM) conditions are globally recognized as the most significant contributors to premature death and disability, demanding an urgent, integrated public health response.

In the realm of oncology, the advent of clinical pathways has gained substantial traction in the past two decades as the increasing cost and complexity of cancer care demanded structured, ...

Implementation of a Lung Cancer Nurse Navigator Enhances Patient Care and Delivery of Systemic Therapy at the British Columbia Cancer Agency, Vancouver The use of clinical pathways in oncology care is ...

New Anglia University is drawing attention to an important development in international medical education: the role of coordinated clinical networks in connecting medical schools with hospitals, ...

As healthcare becomes more entrenched in the digital revolution, the need for an approved set of protocols for care delivery — clinical pathways — is becoming increasingly critical. Clinical pathways, ...